AdvaMed® President and CEO Scott Whitaker released a statement on the announcement by the European Union that COVID-19 vaccines covered by an Advanced Purchase Agreement (APA) require in many instances…
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) issued the following statement from Pat Fogarty, Vice President, Assistant General Counsel, and Director, Civil Justice Policy regarding yesterday’s oral arguments…
WASHINGTON, D.C. – Today AdvaMed® President and CEO Scott Whitaker sent a letter to President Biden affirming the industry’s support of the administration’s national COVID-19 strategy and sharing the industry’s perspective on…
WASHINGTON, D.C. – Today AdvaMed® President and CEO Scott Whitaker released the following statement:
WASHINGTON, D.C. – Today AdvaMed® President and CEO Scott Whitaker released the following statement about AdvaMed®’s participation on the HHS Vaccine Consultation Panel.
WASHINGTON, D.C. – Today, AdvaMed® President and CEO Scott Whitaker commended CMS on the rule the agency released today establishing a new coverage pathway – MCIT – for breakthrough medical technologies:
WASHINGTON, D.C. – The Advanced Medical Technology Association® (AdvaMed®) today named DeChane Dorsey the new Executive Director of AdvaMed Accel®, the division within AdvaMed® dedicated to the needs of small and start-up…
WASHINGTON, D.C. – In a statement today from AdvaMed® President and CEO Scott Whitaker, the world’s largest trade association representing medical technology companies and manufacturers praised California Gov. Gavin Newsom for…
WASHINGTON, D.C. – On behalf of AdvaMed®, the world’s largest trade association representing medical technology companies, President and CEO Scott Whitaker released the following statement:
Washington, D.C. — The MedTech Conference won several International Association of Exhibitions and Events (IAEE) Art of the Show Competition awards, including Best Email Promotion Campaign, Best Show Promotion Website, and tied for the prestigious…